en POLSKI
eISSN: 2719-3209
ISSN: 0023-2157
Klinika Oczna / Acta Ophthalmologica Polonica
Current issue Archive Videos Articles in press About the journal Supplements Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
2/2021
vol. 123
 
Share:
Share:
more
 
 
abstract:
Original paper

Uveal melanoma among octogenarians

Marta Wróblewska-Zierhoffer
1
,
Wojciech Adamski
1
,
Anna Kubiak
2
,
Maciej Trojanowski
2
,
Jarosław Kocięcki
1
,
Iwona Rospond-Kubiak
1

1.
Department of Ophthalmology, Poznan University of Medical Sciences, Poznan, Poland
2.
Greater Poland Cancer Registry, Greater Poland Cancer Centre, Poznan, Poland
KLINIKA OCZNA 2021, 123, 2:80–84
Online publish date: 2021/07/14
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Introduction
To investigate the natural course of the uveal melanoma among octogenarians registered in single centre database.

Material and methods
The data of the patients treated for uveal melanoma at the Department of Ophthalmology, Poznan University of Medical Sciences, Poland between 1991-2017 have been retrospectively reviewed. The survival data were obtained from the Greater Poland Cancer Registry. Patients were included in the study if they were 80 years old or more at time of the onset, they were excluded if there was no confirmed follow-up.

Results
Among 668 uveal melanoma patients registered in our database to 2017, 47 patients were 80 years old or more at the time of treatment: 19 men, 28 women, mean age 83,62 years (range: 80-93). 8 tumours were T1(17%), 12 – T2 (26%), 16 – T3 (34%), and 11 – T4 (23%). 33 (70%) tumours were managed by enucleation, 13 (28%) by ruthenium brachytherapy, 1 (2%) tumour was resected. With regards to irradiated patients we observed 1 recurrence 2 years after treatment. Median follow-up was 21 months (range: 2 to 104 months). 31 patients (66%) died by the study close, 17 (55%) of metastatic disease from uveal melanoma. Median time to metastatic death from uveal melanoma was 24 months.

Conclusions
Metastatic death from uveal melanoma in this particular group of patients was related to tumour size at the onset and epithelioid type of melanoma.

keywords:

survival, uveal melanoma, malignant neoplasm, eye

Quick links
© 2021 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe